Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation (Q40439945)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

20 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Down-regulation of BRCA2 expression by collagen type I promotes prostate cancer cell proliferation (English)

1 reference

20 September 2017

Loredana Moro

1

1 reference

20 September 2017

Arnaldo A Arbini

series ordinal

2

1 reference

20 September 2017

Ersilia Marra

series ordinal

3

1 reference

20 September 2017

Margherita Greco

series ordinal

4

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 April 2005

1 reference

Journal of Biological Chemistry

20 September 2017

1 reference

20 September 2017

280

1 reference

20 September 2017

23

1 reference

20 September 2017

22482-22491

1 reference

Cancer susceptibility and the functions of BRCA1 and BRCA2

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Prostate cancer susceptibility genes: lessons learned and challenges posed

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

BRCA2 is required for homology-directed repair of chromosomal breaks

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal phenotypes of Brca1, Brca2, Brca1/Brca2, Brca1/p53, and Brca2/p53 nullizygous embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Brca2 is required for embryonic cellular proliferation in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Involvement of Brca2 in DNA repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Hallmarks of 'BRCAness' in sporadic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Cytogenetics and molecular genetics of cancer of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Integrin signalling during tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

The cellular basis of site-specific tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Cell adhesion: old and new questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Integrins: versatility, modulation, and signaling in cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Cooperation between soluble factors and integrin-mediated cell anchorage in the control of cell growth and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Mechanisms and consequences of activation of protein kinase B/Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Regulation of beta1C and beta1A integrin expression in prostate carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

p53 mediates repression of the BRCA2 promoter and down-regulation of BRCA2 mRNA and protein levels in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Characterization of BRCA2: temperature sensitivity of detection and cell-cycle regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Type I collagen-mediated proliferation of PC3 prostate carcinoma cell line: implications for enhanced growth in the bone microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Quantification of integrin subunits on human prostatic cell lines--comparison of nontumorigenic and tumorigenic lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

New complexities for BRCA1 and BRCA2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Extracellular matrix enhances heregulin-dependent BRCA1 phosphorylation and suppresses BRCA1 expression through its C terminus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

The ubiquitin-proteasome proteolytic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Roles of ubiquitin-mediated proteolysis in cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Aberrant ubiquitin-mediated proteolysis of cell cycle regulatory proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Regulation of the expression of c-Myc by beta1 integrins in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Akt activation promotes degradation of tuberin and FOXO3a via the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Molecular mechanism of insulin-induced degradation of insulin receptor substrate 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Beta1-integrins are critical for cerebellar granule cell precursor proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Defective Rac-mediated proliferation and survival after targeted mutation of the beta1 integrin cytodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Role of PI3K/AKT/mTOR signaling in the cell cycle progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

The proteasome: a novel target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

PI3K/Akt signalling pathway and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M414091200

Activation of phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma invasion

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1074/JBC.M414091200

Bone cell matrix promotes the adhesion of human prostatic carcinoma cells via the alpha 2 beta 1 integrin

30 December 2023

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1074/JBC.M414091200

Regulation of mitogen-activated protein kinase activation by the cytoplasmic domain of the alpha6 integrin subunit

30 December 2023

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1074/JBC.M414091200

30 December 2023

Identifiers

DOI

10.1074/JBC.M414091200

1 reference

20 September 2017

1 reference